Pricing Log in Create free account

MARKER THERAPEUTICS, INC. (MRKR) vs Pluri Inc. (PLUR)

MARKER THERAPEUTICS, INC. and Pluri Inc. are both Biotechnology companies. MARKER THERAPEUTICS, INC. and Pluri Inc. are of similar size ($15.0M and $14.9M). Pluri Inc. grew revenue faster over the last twelve months: −24.0% against −46.2%. MARKER THERAPEUTICS, INC. has the higher net margin (0.00% vs −2,344.6%) and the lower return on invested capital (−566.8% vs −526.9%). Across the 17 metrics below, MARKER THERAPEUTICS, INC. leads on 11 and Pluri Inc. on 6.

Valuation

Metric MRKR PLUR Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 11.89 9.40
P/B 1.46 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.88 31.96 9.02
Earnings yield (49.75%) (197.58%) (32.88%)
Free cash flow yield (123.23%) (167.21%) (23.13%)

Profitability

Metric MRKR PLUR Biotechnology median
Gross margin 134.12% 44.59% 68.51%
Operating margin 0.00% (2,454.53%) 0.00%
Net margin 0.00% (2,344.59%) 0.00%
Free cash flow margin 0.00% (1,988.48%) 0.00%
Return on equity (76.87%) 260.35% (51.96%)
Return on assets (59.33%) (74.95%) (46.06%)
Return on invested capital (566.75%) (526.92%) 0.00%

Growth

Metric MRKR PLUR Biotechnology median
Revenue growth (TTM) (46.19%) (23.95%) 6.76%
EPS growth (last fiscal year) 33.61% 31.46% 29.88%
Revenue growth, 5-year CAGR 50.02% 113.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRKR PLUR Biotechnology median
Debt to equity 0.07 (1.62) 0.00
Current ratio 6.03 0.27 4.97
Net debt to EBITDA 1.32 (0.83) 1.01

Dividend

Metric MRKR PLUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MRKR PLUR Biotechnology median
Market cap 14.93m 15.00m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack